Table 3. Multivariable Analysis for Vascular Events and All-Cause Mortality in the Overall Population.

	Any stroke		MI		All-cause mortality		MACE
	SHR (95% CI)	p value	SHR (95% CI)	p value	HR (95% CI)	p value	HR (95% CI)	p value
CHD	1.95 (1.89–2.00)	<0.001	1.79 (1.74–1.84)	<0.001	1.02 (1.00–1.05)	0.08	1.41(1.38–1.44)	<0.001

MI, myocardial infarction; MACE, major adverse cardiac events; CHD, congenital heart disease; SHR, sub-distribution hazard ratio; DM, diabetes mellitus; HTN, hypertension; CHF, congestive heart failure; AF, atrial fibrillation; CI, confidence interval.

Variables with p<0.05, in univariable analyses were entered into the multivariable model. Any stroke and all-cause mortality were adjusted for age, sex, DM, HTN, hyperlipidemia, ischemic heart disease, CHF, AF, CHD, antiplatelet agents, anticoagulants, statins, valve replacement, stent insertion, bypass graft, defibrillator, and pacemaker use. MI and MACE were adjusted for age, sex, DM, HTN, hyperlipidemia, CHF, AF, CHD, antiplatelet agents, anticoagulants, statins, valve replacement, stent insertion, bypass graft, defibrillator, and pacemaker use.